Mammalian Glycosyltransferases for use in Chemistry and Biology
用于化学和生物学的哺乳动物糖基转移酶
基本信息
- 批准号:8874755
- 负责人:
- 金额:$ 149.18万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2013
- 资助国家:美国
- 起止时间:2013-09-24 至 2016-06-30
- 项目状态:已结题
- 来源:
- 关键词:AnabolismAutoimmune DiseasesBiochemicalBiologicalBiological ProcessBiologyBiomedical ResearchBiopolymersCarbohydratesCatalysisCell ProliferationCell modelCell surfaceCellsChemicalsChemistryComplexDataDevelopmentDiagnosticDiseaseEmbryonic DevelopmentEnzymesFertilizationFutureGenerationsGenomeGlycobiologyGlycoconjugatesGlycoproteinsGoalsHealthHumanHydroxyl RadicalImageryImmune responseIn SituIndividualInflammationKnowledgeLabelLifeLinkLipidsLocationMalignant NeoplasmsMediator of activation proteinMembraneModificationMolecularMonitorMonosaccharidesNational Research CouncilNucleic AcidsNutraceuticalOligosaccharidesOrganismPathologic ProcessesPathway interactionsPhysiological ProcessesPlayPolysaccharidesProcessProductionProteinsPublishingRecombinantsRelative (related person)ReporterReportingResearch PersonnelResearch Project GrantsResourcesRoleSignal TransductionSiteSpecificityStructureStructure-Activity RelationshipTherapeuticTissuesTranscriptUnited States National Academy of SciencesWorkbasecomplex biological systemsdesignglycosylationglycosyltransferasehuman diseasemacromoleculenext generationnovelnovel therapeuticspathogenpolypeptideprogramsprotein foldingpublic health relevancesugarsugar nucleotidetherapeutic developmenttrafficking
项目摘要
DESCRIPTION (provided by applicant): Complex carbohydrates or glycans are involved in almost every physiological or pathological process. Advances in understanding the biological roles played by glycans, along with the factors that influence or alter their functions will provid important avenues for the development of new therapeutics, and diagnostics. In recognition of opportunities to advance the impact of glycoscience on human health, we have assembled a team of five senior investigators that will work cooperatively on three related research projects to exploit unique capabilities of a Core to produce recombinant mammalian glycosyltransferases. The research projects will 1) study biochemical and structural aspects of glycosyltransferase to define their acceptor specificities at a molecular and structural level 2) exploit the enzymes in a novel chemoenzymatic approach to provide glycans for structure activity relationship studies, aid in the development of the next generation of glycan microarray and as analytical standards; 3) develop sugar nucleotide donors modified by a chemical reporters to label subsets of glycoconjugates for visualization, capture and identification of glycans in cellular models of disease. The three projects have high synergy. Each requires a relatively large panel of glycosyltransferases that will be produced by a core. In addition, they will generate reciprocal knowledge and resources. Project 1 and 3 will perform complementary studies to uncover glycosyl acceptor specificities of glycosyltransferases. Information about glycosyl acceptor specificities of glycosyltransferases will be employed by Project 2 to prepare glycans that otherwise are not accessible by chemo-enzymatic synthesis. Project 2 will generate synthetic glycans that will be employed by Project 1 for in depth studies of glycosyl acceptor specificities. Structural studies by Project 1 will provide important information for project to design of sugar nucleotide donors modified with a chemical reporter for cellular studies in the context of human disease.
描述(由申请人提供):复合碳水化合物或聚糖几乎参与每一个生理或病理过程。了解聚糖所起的生物学作用以及影响或改变其功能的因素的进展将为开发新的治疗方法和诊断方法提供重要途径。认识到有机会促进糖科学对人类健康的影响,我们已经组建了一个由五名高级研究人员组成的团队,他们将在三个相关研究项目上合作,利用a Core的独特能力来生产重组哺乳动物糖基转移酶。该研究项目将1)研究糖基转移酶的生化和结构方面,以确定其在分子和结构水平上的受体特异性2)利用新的化学酶方法为糖基转移酶的结构活性关系研究提供聚糖,帮助开发下一代糖基转移酶微阵列和作为分析标准;3)开发经化学报告修饰的糖核苷酸供体来标记糖缀合物亚群,以便在疾病细胞模型中可视化、捕获和鉴定聚糖。三个项目协同效应强。每一种都需要相对较大的糖基转移酶,这些酶将由一个核心产生。此外,它们将产生相互的知识和资源。项目1和项目3将进行互补研究,以揭示糖基转移酶的糖基受体特异性。关于糖基转移酶的糖基受体特异性的信息将被项目2用于制备化学酶合成无法获得的聚糖。项目2将合成聚糖,项目1将利用这些聚糖对糖基受体特异性进行深入研究。项目1的结构研究将为设计用化学报告基因修饰的糖核苷酸供体项目提供重要信息,用于人类疾病的细胞研究。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Geert-Jan Boons其他文献
Geert-Jan Boons的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Geert-Jan Boons', 18)}}的其他基金
Automated chemo-enzymatic synthesis of N-glycans for host-pathogen interactions
用于宿主-病原体相互作用的 N-聚糖自动化学酶合成
- 批准号:
10626153 - 财政年份:2022
- 资助金额:
$ 149.18万 - 项目类别:
Automated chemo-enzymatic synthesis of N-glycans for host-pathogen interactions
用于宿主-病原体相互作用的 N-聚糖自动化学酶合成
- 批准号:
10521604 - 财政年份:2022
- 资助金额:
$ 149.18万 - 项目类别:
Synthetic multi-component influenza vaccines to elicit broad immunity
合成多成分流感疫苗可引发广泛免疫力
- 批准号:
10458316 - 财政年份:2021
- 资助金额:
$ 149.18万 - 项目类别:
3-O-sulfation of heparan sulfate as a regular of protein function
硫酸乙酰肝素的 3-O-硫酸化作为蛋白质功能的调节
- 批准号:
10615737 - 财政年份:2020
- 资助金额:
$ 149.18万 - 项目类别:
3-O-sulfation of heparan sulfate as a regular of protein function
硫酸乙酰肝素的 3-O-硫酸化作为蛋白质功能的调节
- 批准号:
10400697 - 财政年份:2020
- 资助金额:
$ 149.18万 - 项目类别:
Streamlining the chemoenzymatic synthesis of asymmetrical glycans of biological importance
简化具有生物学重要性的不对称聚糖的化学酶合成
- 批准号:
9752086 - 财政年份:2016
- 资助金额:
$ 149.18万 - 项目类别:
Streamlining the chemoenzymatic synthesis of asymmetrical glycans of biological importance
简化具有生物学重要性的不对称聚糖的化学酶合成
- 批准号:
9533657 - 财政年份:2016
- 资助金额:
$ 149.18万 - 项目类别:
Streamlining the chemoenzymatic synthesis of asymmetrical glycans of biological importance
简化具有生物学重要性的不对称聚糖的化学酶合成
- 批准号:
9749989 - 财政年份:2016
- 资助金额:
$ 149.18万 - 项目类别:
Streamlining the chemoenzymatic synthesis of asymmetrical glycans of biological importance
简化具有生物学重要性的不对称聚糖的化学酶合成
- 批准号:
9166183 - 财政年份:2016
- 资助金额:
$ 149.18万 - 项目类别:
Mammalian Glycosyltransferases for use in Chemistry and Biology
用于化学和生物学的哺乳动物糖基转移酶
- 批准号:
8740506 - 财政年份:2013
- 资助金额:
$ 149.18万 - 项目类别:
相似国自然基金
Autoimmune diseases therapies: variations on the microbiome in rheumatoid arthritis
- 批准号:31171277
- 批准年份:2011
- 资助金额:60.0 万元
- 项目类别:面上项目
相似海外基金
Effects of maternal immune activation on autoimmune diseases in offsprings
母体免疫激活对后代自身免疫性疾病的影响
- 批准号:
23H02155 - 财政年份:2023
- 资助金额:
$ 149.18万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Autoantibodies and antibody-secreting cells in neurological autoimmune diseases: from biology to therapy
神经性自身免疫性疾病中的自身抗体和抗体分泌细胞:从生物学到治疗
- 批准号:
479128 - 财政年份:2023
- 资助金额:
$ 149.18万 - 项目类别:
Operating Grants
IPP: AUTOIMMUNE DISEASES STATISTICAL AND CLINICAL COORDINATING CENTER (ADSCCC)
IPP:自身免疫性疾病统计和临床协调中心 (ADSCCC)
- 批准号:
10788032 - 财政年份:2023
- 资助金额:
$ 149.18万 - 项目类别:
Biomarkers of vascular endothelial dysfunction in systemic autoimmune diseases: analysis of circulating microRNAs
系统性自身免疫性疾病中血管内皮功能障碍的生物标志物:循环 microRNA 分析
- 批准号:
23K14742 - 财政年份:2023
- 资助金额:
$ 149.18万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
NOVEL HUMORAL AND CELLULAR BIOMARKERS OF AUTOIMMUNE DISEASES CAUSED BY IMMUNOTHERAPY
免疫治疗引起的自身免疫性疾病的新型体液和细胞生物标志物
- 批准号:
10593224 - 财政年份:2023
- 资助金额:
$ 149.18万 - 项目类别:
Structural mechanisms of autoimmune diseases targeting cys-loop receptors
针对半胱氨酸环受体的自身免疫性疾病的结构机制
- 批准号:
10864719 - 财政年份:2023
- 资助金额:
$ 149.18万 - 项目类别:
Developing non-immunosuppressive immune-based therapeutics for targeted treatment of autoimmune diseases
开发非免疫抑制性免疫疗法来靶向治疗自身免疫性疾病
- 批准号:
10586562 - 财政年份:2023
- 资助金额:
$ 149.18万 - 项目类别:
Regulation of autoimmune diseases by PTPN22 phosphatase
PTPN22磷酸酶对自身免疫性疾病的调节
- 批准号:
23K06589 - 财政年份:2023
- 资助金额:
$ 149.18万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Decipher and target GABA metabolism and GABA receptor-mediated signaling in autoimmune diseases
破译并靶向自身免疫性疾病中的 GABA 代谢和 GABA 受体介导的信号传导
- 批准号:
10623380 - 财政年份:2023
- 资助金额:
$ 149.18万 - 项目类别:
Targeting the long isoform of the prolactin receptor to treat autoimmune diseases and B-cell malignancies
靶向催乳素受体的长亚型来治疗自身免疫性疾病和 B 细胞恶性肿瘤
- 批准号:
10735148 - 财政年份:2023
- 资助金额:
$ 149.18万 - 项目类别: